Deep Survival Analysis with Temporal Trajectory Embedding for Substandard Life Insurance Pricing: A DeepSurv Modeling Study of Type 2 Diabetes Mellitus

For millions of people living with chronic conditions like type 2 diabetes, the path to financial security is often blocked by a simple, harsh reality: insurance companies cannot price their risk accurately. Traditional methods for calculating life insurance premiums rely on static snapshots, treating a person's health as a fixed label at the moment they apply. However, chronic diseases are not static; they are dynamic journeys that change over time, often accelerating as complications arise. When insurers cannot see the full picture of how a disease progresses or how different health issues interact, they face a dilemma. To avoid losing money, they often reject applicants outright or charge prohibitively high premiums that make coverage unaffordable. This leaves a vast population of "impaired lives"—people with manageable but serious conditions—marginalized from the protection networks that society relies on. The core challenge is not just a lack of data, but a lack of tools capable of understanding the complex, non-linear way that health deteriorates and how different medical conditions amplify one another.

A team of researchers at the University of International Business and Economics in Beijing has tackled this problem by building a new kind of pricing engine designed specifically for these complex cases. Using a massive dataset of nearly 1.9 million hospital records from people with type 2 diabetes, they moved beyond the old, linear formulas that assume risks simply add up. Instead, they employed a sophisticated artificial intelligence system known as DeepSurv, which is capable of mapping the intricate, hidden relationships between different health factors. The researchers found that the old methods were fundamentally flawed. A traditional approach that simply compared groups of patients resulted in a bizarre and unfair error: it suggested that patients with moderate complications were actually at higher risk than those with severe, life-threatening organ damage. This happened because the old tools failed to separate the effect of the disease itself from the age of the patients, confusing an older age group with a more severe condition.

To fix this, the researchers constructed a model that learns from the data much like a human expert would, but with the ability to process millions of variables simultaneously. They trained this system on over 1.8 million records, teaching it to recognize patterns in how diabetes progresses and how it interacts with other conditions like heart failure and kidney disease. The system uses a technique called Elastic Net regularization, which acts as a filter to identify the most important risk factors while ignoring noise. In doing so, it revealed that the true drivers of risk are often not the diabetes diagnosis itself, but the specific cardiovascular complications that accompany it. The model successfully identified that the presence of heart failure and chronic ischemic heart disease are nearly as critical to pricing as the stage of the diabetes itself, a nuance that previous linear models missed entirely.

The study also explored the value of time. While the main model looked at a snapshot of risk, the researchers ran a separate experiment to see if tracking a patient's health history over time improved predictions. They found that looking at the sequence of a patient's hospital visits and expenses did provide extra insight, particularly for those in the middle stages of the disease whose health is still changing. However, the most powerful tool remained the ability to map the complex web of interactions between different diseases. The researchers confirmed their findings were robust by repeatedly testing the model on different slices of the data, ensuring the results were not just a lucky guess. The model proved stable, consistently ranking risk levels with high accuracy across thousands of simulations.

Perhaps the most significant breakthrough was making this complex AI understandable. Because insurance is a regulated industry, a "black box" that gives a price without explanation is useless. The researchers used a method called SHAP to break down exactly why the model assigned a specific price to a specific person. They demonstrated that the system could clearly attribute the cost to specific factors: age, the stage of diabetes, and the presence of heart conditions. For example, in a case study of a 65-year-old man with heart failure, the model calculated a premium of 14,802 RMB. A traditional method would have charged him only about 10,630 RMB, dangerously underestimating his true risk. The new model, by contrast, provided a fair price that reflected his actual medical reality, while also showing exactly how much each condition contributed to that cost.

The researchers also showed how this system could be used to reward healthy behavior. They integrated a factor that lowers the premium if a patient actively manages their health, such as sticking to a medication regimen or attending regular check-ups. This creates a direct financial incentive for patients to stay healthy, turning insurance from a static contract into a dynamic partnership. The study concludes that by replacing rigid, linear formulas with flexible, deep learning models, the insurance industry can finally offer fair, transparent, and affordable coverage to the millions of people who have long been excluded. The work proves that with the right tools, it is possible to price risk accurately without sacrificing fairness, ensuring that those with chronic conditions are not left behind.